Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Frost & Sullivan | PRODUCT CODE: 1844027

Cover Image

PUBLISHER: Frost & Sullivan | PRODUCT CODE: 1844027

Second Skin Diagnostics: Innovations and Growth Opportunities, 2025-2029

PUBLISHED:
PAGES: 30 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
Web Access (Regional License)
USD 4950

Add to Cart

Wearable diagnostic patches are revolutionizing non-invasive health monitoring, enabling real-time detection of biomarkers for personalized care

Second skin diagnostics refers to the emerging class of ultra-thin, flexible biosensors designed to adhere seamlessly to the skin and continuously monitor a range of physiological signals in real time. Made from stretchable, skin-like materials, these wearables can track vital signs and biomarkers, such as temperature, hydration, glucose, and heart rate, through non-invasive contact with sweat or skin. Equipped with wireless communication capabilities, these devices are designed for comfort, long-term use, and integration into remote health monitoring systems.

This report provides an in-depth analysis of the emerging field of second skin diagnostics, focusing on microfluidic and bioelectronic patches used for disease diagnosis. It examines the technological landscape, market readiness, stakeholder activities, and innovation patterns in these segments. The report also offers a comprehensive analysis of the global contract development and manufacturing organization (CDMO) landscape supporting second skin diagnostics development on sensors, adhesives, microfluidics, or battery components. It also identifies the key growth opportunities in second skin diagnostics, focusing on emerging technologies, integration potential, and market enablers that can drive second skin diagnostics from an adjunct tool to standalone diagnostic solutions.

Our latest report explores how second skin diagnostics are transforming the healthcare landscape. By combining microfluidics, flexible electronics, and biosensors, these innovative solutions offer a non-invasive alternative to traditional diagnostic modalities.

The report examines how this technology is shifting diagnostics from the lab to the skin - improving accessibility, speeding up results, and supporting more personalized care.

Discover how second skin diagnostics are paving the way for decentralized, patient-friendly healthcare.

Product Code: DB2E

Table of Contents

Strategic Imperatives

  • Why Is It Increasingly Difficult to Grow?
  • The Strategic Imperative 8
  • The Impact of the Top 3 Strategic Imperatives on the Second Skin Diagnostics Industry
  • Growth Opportunities Fuel the Growth Pipeline Engine
  • Research Methodology

Growth Opportunity Analysis

  • Scope of Analysis
  • Segmentation
  • Skin and its Role in Diagnostics
  • Key Industry Shifts in Second Skin Diagnostics

Growth Generator

  • Growth Drivers
  • Growth Restraints

Bioelectronic Second Skin Diagnostics: Technology Analysis

  • Key Players Involved in Bioelectronic Second Skin Diagnostics
  • Key Academic Players Involved in Bioelectronic Second Skin Diagnostics
  • Technology and Stakeholder Analysis: Bio-electronic Second Skin Diagnosis

Microfluidic Second Skin Diagnostics: Technology Analysis

  • Key Players Involved in Microfluidic Second Skin Diagnostics
  • Key Academic Players Involved in Microfluidic Second Skin Diagnostics
  • Technology and Stakeholder Analysis: Microfluidic Second Skin Diagnostics

Stakeholder Activities: Insights on Funding, Partnerships, and Acquisitions

  • Patent Analysis for Second Skin Diagnostics
  • Private Funding Activities in Second Skin Diagnostics
  • Public Funding Activities in Second Skin Diagnostics
  • Strategic Partnerships Shaping Second Skin Diagnostics
  • Analyst Insights on the Stakeholder Activities of Second Skin Diagnostics

Enabling Second Skin Diagnostics with CDMOs

  • Advanced Skin-interfacing Materials & Patch Technology Providers
  • Global Landscape of CDMO and CDRO for Second Skin Diagnostics, by Region
  • Sensors and Printed Electronics CDMOs and CDROs Lead the Second Skin Diagnostic Landscape

Growth Opportunity Universe in Second Skin Diagnostics

  • Growth Opportunity 1: Integration with AI-driven Predictive Diagnostics
  • Growth Opportunity 2: Multimodal Sensing Patches
  • Growth Opportunity 3: Integration with Digital Health Ecosystems

Appendix

  • Technology Readiness Levels TRL: Explanation

Next Steps

  • Benefits and Impacts of Growth Opportunities
  • Next Steps
  • Legal Disclaimer
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!